Microbot Medical Exercises Option to Acquire Novel Technology from CardioSert Ltd.

NEXT STORY
Novavax Announces Closing of Public Offering
PREV STORY
Relypsa Funds Three Innovative Research Projects on Hyperkalemia and Associated Disorders
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., and BEIJING, China, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

author_avatar
NASDAQ Market News

Diffusion Pharmaceuticals Appoints Biotech Industry Veteran Isaac Blech to Board of Directors

CHARLOTTESVILLE, Va., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical ...

author_avatar
NASDAQ Market News

Pluristem Completes Enrollment of 150 Patients in Phase II Intermittent Claudication Trial

Trial expands to randomize 20 more patients to receive two injections per patientData release ...

author_avatar
NASDAQ Market News